Occudo Quantitative Strategies’s Advent Technologies ADN Stock Holding History
Bought
Maintained
Sold
Other funds holding ADN
PSCM
Occudo Quantitative Strategies's ADN Position: Q2 2022 in Review
Occudo Quantitative Strategies sold out of Advent Technologies (ADN) in Q2 2022, closing a stake of 1,558 shares — an estimated $108K sold.
Occudo Quantitative Strategies first reported a position in ADN in Q2 2021 and held it in 3 quarters. The position peaked at $507K in Q2 2021. 49 funds tracked by Wall St. Rank hold ADN as of Q2 2022.
- Occudo Quantitative Strategies reported no remaining Advent Technologies position as of Q2 2022 after selling out during the quarter.
- Occudo Quantitative Strategies sold 1,558 Advent Technologies shares in Q2 2022, an estimated $108K.
- Occudo Quantitative Strategies first reported a position in Advent Technologies in Q2 2021 and held it in 3 quarters.
- Occudo Quantitative Strategies's Advent Technologies position peaked at $507K in Q2 2021.
- 49 funds tracked by Wall St. Rank held Advent Technologies as of Q2 2022.
Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.